The body of science showing that ketamine, the drug is best known for its recreational use, might one day become a prominent treatment for depression is growing.
A new study published April 11 in the journal Science shows that not only does ketamine offer fast-acting and temporary relief for depression, but the drug appears to actively repair damaged brain circuits, as well. So far, evidence of such reparative effects has only been tested in mice, but if it winds up proving to have a similar effect in humans it may constitute a breakthrough in treating the mental illness.
Read more of the research’s findings on QUARTZ.